TD Cowen Upgrades Moderna to Outperform From Market Perform, Adjusts Price Target to $180 From $150
MT NEWSWIRES
8:55 AM ET 03/13/2023
08:55 AM EDT, 03/13/2023 (MT Newswires) -- Moderna(MRNA) has an average rating of outperform and price targets ranging from $93 to $506, according to analysts polled by Capital IQ.